Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Kiropraktik Danmark ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   8.5% 11.2% 11.5% 10.1% 7.3% 11.7% 15.9% 15.9%   Credit score (0-100)   30 21 20 23 32 20 12 12   Credit rating   BB BB BB BB BBB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   93.5 82.6 45.6 60.4 105 207 0.0 0.0   EBITDA   93.5 82.6 45.6 60.4 105 -79.4 0.0 0.0   EBIT   74.4 63.5 45.6 60.4 88.0 -102 0.0 0.0   Pre-tax profit (PTP)   114.0 103.7 90.0 106.0 108.3 -85.0 0.0 0.0   Net earnings   88.9 80.8 70.2 82.7 83.9 -66.3 0.0 0.0   Pre-tax profit without non-rec. items   114 104 90.0 106 108 -85.0 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   19.1 0.0 0.0 0.0 95.6 73.1 0.0 0.0   Shareholders equity total   910 991 1,061 1,144 527 461 381 381   Interest-bearing liabilities   0.0 0.0 0.0 0.0 30.0 30.0 0.0 0.0   Balance sheet total (assets)   1,001 1,107 1,138 1,222 600 517 381 381   Net Debt   -23.7 -8.0 -58.0 -57.1 -25.7 21.3 -381 -381     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   93.5 82.6 45.6 60.4 105 207 0.0 0.0   Gross profit growth   -56.5% -11.6% -44.8% 32.5% 73.6% 97.8% -100.0% 0.0%   Employees   2 1 0 0 0 1 0 0   Employee growth %   -50.0% -50.0% -100.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,001 1,107 1,138 1,222 600 517 381 381   Balance sheet change%   4.8% 10.6% 2.8% 7.4% -50.9% -13.8% -26.4% 0.0%   Added value   93.5 82.6 45.6 60.4 88.0 -79.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -38 -38 0 0 79 -45 -73 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 -1.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   79.6% 76.9% 100.0% 100.0% 83.9% -49.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   11.7% 9.9% 8.0% 9.0% 11.9% -13.2% 0.0% 0.0%   ROI %   13.2% 11.0% 8.8% 9.6% 12.8% -14.0% 0.0% 0.0%   ROE %   10.3% 8.5% 6.8% 7.5% 10.0% -13.4% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   95.2% 92.8% 97.2% 95.1% 87.9% 89.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -25.3% -9.7% -127.1% -94.5% -24.5% -26.8% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 5.7% 6.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 2.9% 38.1% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   21.3 14.1 36.6 20.8 7.2 8.2 0.0 0.0   Current Ratio   10.8 9.5 14.7 15.6 7.2 8.2 0.0 0.0   Cash and cash equivalent   23.7 8.0 58.0 57.1 55.7 8.7 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   890.7 990.6 1,060.8 1,143.5 434.2 390.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   47 83 0 0 0 -79 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   47 83 0 0 0 -79 0 0   EBIT / employee   37 64 0 0 0 -102 0 0   Net earnings / employee   44 81 0 0 0 -66 0 0